168 related articles for article (PubMed ID: 34672133)
1. Medications and the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Use of the Landmark Method.
Choi YY; Lee JK; Kim HS; Kim DW; Kim HM; Kang DR
Yonsei Med J; 2021 Nov; 62(11):997-1004. PubMed ID: 34672133
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
[No Abstract] [Full Text] [Related]
3. Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018.
King D; Reulen RC; Thomas T; Chandan JS; Thayakaran R; Subramanian A; Gokhale K; Bhala N; Nirantharakumar K; Adderley NJ; Trudgill N
Aliment Pharmacol Ther; 2020 May; 51(10):922-934. PubMed ID: 32237083
[TBL] [Abstract][Full Text] [Related]
4. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
[TBL] [Abstract][Full Text] [Related]
5. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
6. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Collins PD; Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2006 Apr; (2):CD000279. PubMed ID: 16625534
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.
Linson EA; Hanauer SB
Curr Gastroenterol Rep; 2021 Aug; 23(9):16. PubMed ID: 34338892
[TBL] [Abstract][Full Text] [Related]
8. [Inflammatory bowel disease and colorectal cancer].
Hagymási K; Tulassay Z
Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
[TBL] [Abstract][Full Text] [Related]
9. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
[TBL] [Abstract][Full Text] [Related]
10. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
11. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
Bernstein CN; Nugent Z; Blanchard JF
Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
[TBL] [Abstract][Full Text] [Related]
12. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
[TBL] [Abstract][Full Text] [Related]
13. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
14. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
[TBL] [Abstract][Full Text] [Related]
15. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
Qiu X; Ma J; Wang K; Zhang H
Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet Gastroenterol Hepatol; 2020 May; 5(5):475-484. PubMed ID: 32066530
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of pneumonia among patients with inflammatory bowel disease.
Long MD; Martin C; Sandler RS; Kappelman MD
Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
[TBL] [Abstract][Full Text] [Related]
18. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Harmsen WS; Zinsmeister AR; Smyrk TC; Schleck CD; Tremaine WJ; Melton LJ; Munkholm P; Sandborn WJ
Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397
[TBL] [Abstract][Full Text] [Related]
19. Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis.
Jess T; Lopez A; Andersson M; Beaugerie L; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1793-1800.e1. PubMed ID: 24907505
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
